This differential fit was associated with a small number of participants possessing high overall tau deposition, but having deposition patterns that did not map onto the anticipated progression of AD tau deposition spread (starting in the transentorhinal cortex and ending in primary visual cortex) [8, 9]. The gene discussed is MAPT; the disease is Alzheimer disease.